SeedRound Media
Rushed for time? Here is the top 5 Early Stage Venture investors for Venture Capital startups. Scroll down for more information on these investors or to view the rest of the investors.
Name | Website | Stages | Location | Socials |
|---|---|---|---|---|
General Catalyst | Early Stage Venture, Late Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
Atlas Venture | Early Stage Venture, Late Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
F-Prime Capital | Early Stage Venture, Late Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
Accomplice | Early Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
MPM Capital | Early Stage Venture, Late Stage Venture, Private Equity, Seed | Cambridge, Massachusetts, United States, North America |
At SeedRound we track over 200,000 investors and over 1,000,000 people who hold key positions in these firms. We use this directory of investors to highlight top employees, LP’s and funding organisations we think deserve more appreciation than they are currently getting.
We’ve ranked the top Venture Capital Early Stage Venture investors in Cambridge. The companies, startups and institutions listed in this article are all exceptional companies, well worth a follow. We have included links to their websites, socials and CrunchBase (if you’re interested in their financials).
We selected the organisations listed in this article based on:
- Track record
- Executive leadership
- Market share
- Innovation
- ESG rating
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Top Venture Capital Investors & Funds (Cambridge)
General Catalyst
General Catalyst is a venture capital firm that provides early-stage and growth equity investments. They provide ongoing momentum that accelerates ideas, careers, and companies toward standout success. They create the ideal conditions for growth, surround clients with the right people, and offer mentorship based on deep experience. To date, General Catalyst has managed eight venture capital funds totaling approximately $3.75 billion in capital commitments.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Asset Management, Finance, Financial Services, Venture Capital
Follow:
Atlas Venture
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Biotechnology, Health Care, Pharmaceutical, Venture Capital
Follow:
F-Prime Capital
F-Prime’s roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, this venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today, F-Prime’s funds are larger and more global, but its teams are still small and local. F-Prime stays true to its entrepreneurial roots. In the US and Europe, F-Prime Capital Partners is investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, its sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together F-Prime brings a world of insight, domain expertise and relationships to support entrepreneurs. Without the pressure of fundraising from outside investors, F-Prime Capital Partners focuses all of its time finding and helping great entrepreneurs build important companies.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Business Development, Finance, Financial Services, Venture Capital
Follow:
Accomplice
Accomplice is a seed-led venture capital firm that invests in technology startup companies. Its specialties are cybersecurity, eSports, data analytics, SMB class software, emerging hardware platforms, and marketplaces. Through platforms like AngelList, Boston Syndicates, and Maiden Lane, Accomplice harnesses the community to empower and fund the best founders. It has pioneered a community approach through platforms like Spearhead, BOSS, Rev, and TUGG. A majority of Accomplice’s investments are in Boston, with others throughout the U.S., Canada, and the E.U. Formerly known as Atlas Venture, the firm announced in October 2014 that it was splitting its technology and life sciences franchises. The technology group was renamed Accomplice; the life sciences group retained the name Atlas Venture. Headquartered in Cambridge, Massachusetts, Accomplice is one of the most active early-stage firms in New England.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Business Development, Finance, Financial Services, Venture Capital
Follow:
MPM Capital
MPM Capital is a healthcare investment firm that invests in early-stage companies developing innovative therapeutic technologies in oncology. The firm is founding and investing in life sciences companies both public and private that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. MPM Capita will focus on disruptive scientific developments across multiple therapeutic areas including oncology, immunology, and neuroscience as well as emerging modalities of the cell, gene, and nucleic acid therapies. With its experienced and dedicated team of investment professionals, executive partners, entrepreneurs, and scientific advisory board members, MPM is powering novel medical breakthroughs that transform patients’ lives. MPM Capital was founded in 1996 and is headquartered in Cambridge, Massachusetts, United States.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Biotechnology, Health Care, Life Science, Venture Capital
Follow:
Amadeus Capital Partners
Amadeus Capital is a global technology investor that invests in technology companies at all stages, from seed to venture buyout; they also buy stakes from other investors or founders, to ensure that companies and entrepreneurs have the runway they need to succeed. They invest in a broad variety of sectors including enterprise and infrastructure software, consumer and business services, medical technology and healthcare IT, and cleantech and resource efficiency. It has the imagination to see where new businesses can be created and the technical insight, operational experience and global network to help entrepreneurs make their vision a reality. The Company was founded in 1997 and since has backed more than 130 companies and raised over $1bn for investment.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. They accelerate Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology. Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies. They attract, develop, and retain the top scientific, entrepreneurial, and managerial talent in the world.
Stages: Debt, Early Stage Venture, Late Stage Venture, Private Equity
Location: Cambridge, Massachusetts, United States, North America
Industries: Biotechnology, Business Development, Finance, Health Care, Venture Capital
Follow:
IQ Capital
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including to Apple, Huawei, Google and Oracle.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Financial Services, Information Technology, Venture Capital
Follow:
Cambridge Angels group
Cambridge Angels is a group of more than 60 high-net worth investors who have proven experience as successful entrepreneurs. Members invest in and mentor high quality start-up and early-stage companies in Cambridge, London, Oxford and throughout the UK.
Typical funding requirements that Cambridge Angels meet are in the range of £150k to £1.5m – although it is worth noting that several of our portfolio companies have raised significant follow-on funding from our Members and our venture capital partners over several funding rounds.
Our Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Angel Investment, Financial Services, Venture Capital
Follow:
HealthCare Ventures
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Stages: Debt, Early Stage Venture, Late Stage Venture, Private Equity
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
SyndicateRoom
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story. To do this – and make fund investors money – we don’t try to spot the next Big Thing. Instead, we apply a data-driven model to portfolio construction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour. Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Stages: Early Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: FinTech, Venture Capital
Follow:
Cambridge Innovation Capital
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Stages: Early Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Intellectual Property, Venture Capital
Follow:
Fairhaven Capital Partners
Fairhaven Capital Partners (previously [TD Capital](http://www.crunchbase.com/financial-organization/td-capital)) is a Cambridge, Massachusetts based venture capital firm investing in early stage, high potential companies with rapid growth characteristics.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
Castle Island Ventures
They are a venture capital firm focused exclusively on public blockchains. They invest in infrastructure and application companies that will enable these transformative protocols to power services for the next billion users.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Venture Capital
Follow:
Mission BioCapital
Mission BioCapital is a life science venture capital firm that invests in early-stage companies. The company leadership team has a long history together, investing in and launching dozens of early-stage life science companies. They are located in regions with a rich concentration of research, discovery, and venture capital investment, and they are known by leaders of portfolio companies for the expertise and deep support they provide.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Life Science, Medical, Venture Capital
Follow:
The Engine
The Engine, which was publicly announced on October 26, 2016, was built by the Massachusetts Institute of Technology (MIT). Prioritizing breakthrough ideas over early profit, The Engine represents an exciting new system for startup support, one that shortens the time from idea to investment, and from investment to impact. To fuel The Engine, MIT is seeking to attract hundreds of millions of dollars of support and to provide hundreds of thousands of square feet of space for entrepreneurs in Kendall Square and nearby communities, starting with 26,000 square feet in its Central Square headquarters. The Engine provides a physical space where an idea can begin to take shape. It also streamlines the legal processes and agreements required to get products to market. And it links entrepreneurs to “patient capital” from investors who share their vision of addressing big challenges with big ideas. The Engine will eventually support up to 60 locally based startups concurrently; these companies will participate in the accelerator for up to 12 months. The Engine will make meaningful investments that will allow participating startups to get off the ground quickly and operate long enough to prove their concepts’ viability. It will also provide business planning, legal, and administrative support. The Engine will require less equity than is typical, allowing founders to maintain more control over their companies and the ideas they’ve created. Through the Engine Room, The Engine will provide access to a wide network of lab space, specialized equipment, business guidance, and other resources, at MIT and beyond.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Angel Investment, Incubators, Social Impact, Venture Capital
Follow:
Safar Partners
Safar Partners is a seed- to growth-stage venture fund investing primarily in technology companies out of MIT, Harvard, and the University of Rochester. We invest in platform technologies in the cleantech and advanced materials, AI/IT and robotics, and life science/medical device areas.
Stages: Early Stage Venture, Late Stage Venture, Seed, Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Venture Capital
Follow:
Tamarisc Ventures
Tamarisc is an early stage venture capital firm. We invest in real estate technology companies that improve how we live, work, and travel within the built environment.
Stages: Convertible Note, Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Hospitality, Information Technology, Real Estate, Venture Capital
Follow:
Qiming Venture Partners USA
Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leading investment firm in China and currently manage four funds with over $1 billion in assets.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Financial Services, Information Technology, Venture Capital
Follow:
Blue Haven Initiative
Blue Haven Initiative is a family office action tank that focuses on how a family can impact the world by investing different kinds of capital and communicating that story to inspire others. The firm is focused primarily on early-stage companies in emerging and pioneer markets.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Angel Investment, Real Estate, Venture Capital
Follow:
TTP Ventures
TTP Ventures provides venture capital for IT and clean technology companies based in the UK. It is currently managing a £34m first fund
Stages: Early Stage Venture, Late Stage Venture
Location: Melbourn, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Action Potential Venture Capital
GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012 after a two-year effort to seek out and engage the most promising researchers in this emerging area of science. The name of the fund comes from electrical signals called action potentials that pass along the nerves in the body. Irregular or altered patterns of these impulses may occur in association with a broad range of diseases. GSK believes that miniaturised devices, or bioelectronic medicines, can be designed to read these patterns. The devices could be designed to interface between the peripheral nervous system and specific organs to read, change or generate electronic impulses that help treat disorders as diverse as inflammatory bowel disease or rheumatoid arthritis; respiratory diseases such as asthma and COPD and metabolic diseases including Type 2 diabetes. The field of bioelectronic medicines is in its very early stages. GSK’s ambition, through collaboration with scientists globally, is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.“We want to help create the medicines of the future and be the catalyst for this work,” said Moncef Slaoui, chairman of R&D and architect of GSK’s early stage investment strategy. “GSK can play the integrating role that is needed to drive this new type of medical treatment all the way from the bench to the patient and this fund is a key part of our efforts.” Action Potential Venture Capital intends to build a portfolio of five to seven companies over the next five years. The fund will focus investments in three areas: – New start-up companies that aim to pursue the vision of bioelectronic medicines – Existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses – Companies advancing technology platforms that will underpin these treatment modalities Action Potential Venture Capital will be based in Cambridge, Massachusetts and managed by a small, dedicated team. The fund has named Imran Eba as its first partner. Imran will move from GSK’s Worldwide Business Development organisation and work closely with the Bioelectronics R&D unit.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Venture Capital
Follow:
Avlar BioVentures
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
Stages: Early Stage Venture, Late Stage Venture
Location: Madingley, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Fresh Source Capital
Fresh Source Capital is an investment firm focused on sustainable food and agriculture. FSC focus on seed and growth stage companies based in North America. Our investments include equity and structured exit instruments such as subordinated debt and royalty financing.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Agriculture, Organic Food, Venture Capital
Follow:
Suffolk Equity Partners
Suffolk Equity Partners was founded in 2011 as an investment vehicle focused on finding businesses and entrepreneurs of promise. We seek companies and people we believe in, and help them achieve their goals of growth and improvement. With experience in finance, distribution, retail, operational management, and family business, the Suffolk Equity team believes in portfolio diversity and finding thoughtful ways to add value to our portfolio companies.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Angel Investment, Finance, Venture Capital
Follow:
Brookline Venture Partners
Brookline Venture Partners was founded in 2004 to invest in early-stage companies. Its founders are entrepreneurs with operational, financial, and sales experience. BVP partners Ken Levine and Mark Goodman bring a wealth of experience to their portfolio companies, providing strategic and tactical advice to management teams as they navigate the numerous challenges facing start-up companies.
Stages: Early Stage Venture, Late Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
Invoke Capital
Invoke Capital Partners was founded by Dr Mike Lynch, members of the senior management team from Autonomy, and a group of technology experts, with access to $1bn in capital. Invoke is focused on maximizing the potential of European fundamental technology by using its unique expertise and repositioning experience to rapidly scale them across multiple markets. It is the only investment team in Europe with a dedicated, in-house R&D division, based in Cambridge, UK. The Invoke team has grown multiple technology businesses with particular expertise and experience in science and technology allowing them to identify and develop core technologies in areas including genomics, security, pattern recognition, signal processing and big data.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Acacia Capital Partners
Acacia Capital Partners is an independent management company made up of experienced venture capitalists with in-depth operational and investment management experience. They invest in later stage innovative technology companies both directly and indirectly.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Terawatt Ventures
Terawatt Ventures is a venture capital company that provides businesses to enterprises which address global energy challenges. It was founded in 2009 by Mark Goodman and is based in Massachusetts.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Venture Capital
Follow:
Fund Twenty8
Smart Beta for Early stage investing – Fund Twenty8 The fund is the first passive EIS fund for early stage investments. It will deliver a multi-sector and large portfolio for investors. They believe Fund Twenty8 addresses two key areas currently underserved by the EIS fund market. A lack of sector diversification within a fund and a failure to benefit from a wide portfolio approach investing. Traditional early stage funds usually focus on a single sector (exposing investors to sector-specific risks) and usually only invest in 5 to 8 investments per fund. They feel there is a need in the market for a multi-sector and large portfolio fund for early stage investments. That’s why they created Fund Twenty8. Fund Twenty8 offers investors access to a diversified portfolio with at least 28 investments per fund and across multiple sectors.
Stages: Early Stage Venture, Private Equity, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
BioInnovation
BioInnovation LLC, based in Cambridge, Massachusetts, is an early stage life sciences investment and consulting firm. We make seed investments, act as institutional co-founders, and provide strategic and operational services. As investors and entrepreneurs ourselves, we understand the needs of early-stage companies, and the end-to-end requirements needed to start, grow and build successful ventures.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Consulting, Life Science, Venture Capital
Follow:
NW Brown Ventures
NW Brown was founded in Cambridge in 1974 and has grown alongside the city’s thriving economy. In 2009, they purchased a Norwich-based company of financial advisers with a similar philosophy of providing clients with quality service.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
The Engine
The Engine, built by MIT, is a venture firm that invests in early-stage companies solving the world’s biggest problems through the convergence of breakthrough science, engineering, and leadership.
Stages: Early Stage Venture, Private Equity, Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Venture Capital
Follow:
Primera Impact
Primera Impact is a collaboration between researchers at the University of Cambridge and Primera Capital, a San Francisco-based venture capital fund. We aim to catalyse ideas that demonstrate promise towards making the world a better place.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Financial Services, Venture Capital
Follow:
